View More View Less
  • 1 Ladoke Akintola University of Technology (LAUTECH), Osogbo, Osun State, Nigeria
  • | 2 Afe Babalola University, P.M.B. 5454, Ado Ekiti, Ekiti State, Nigeria
Open access

Acinetobacter baumannii is a ubiquitous pathogen that has emerged as a major cause of healthcare-associated infections at Ladoke Akintola University Teaching Hospital. Isolates were assayed according to standard protocol. The isolates were subjected to molecular techniques to detect blaOXA, blaTEM, blaCTX-M, and blaSHV genes in strains of the A. baumannii isolates.

The prevalence of A. baumannii was 8.5% and was most prevalent among patients in the age group 51–60 (36%); the male patients (63.6%) were more infected than their female counterparts. Patients (72.7%) in the intensive care unit (ICU) were most infected with this organism. The isolates showed 100% resistance to both amikacin and ciprofloxacin and 90.9% to both ceftriaxone and ceftazidime, while resistance to the other antibiotics used in this study were: piperacillin (81.8%), imipenem (72.7%), gentamycin (72.2%), and meropenem (63.6%). None of the isolates was, however, resistant to colistin. PCR results showed that blaOXA, blaTEM, and blaCTX-M genes were positive in some isolates, while blaSHV was not detected in any of the isolates.

This study has revealed that the strains of A. baumannii isolated are multiple drug resistant. Regular monitoring, judicious prescription, and early detection of resistance to these antibiotics are, therefore, necessary to check further dissemination of the organism.

  • 1.

    Bergogne-Berezin E , Towner KJ: Acinetobacter spp. as nosocomial pathogen: microbiological, clinical and epidemiological features. Clin Microbiol Rev 14865 (1996)

    • Search Google Scholar
    • Export Citation
  • 2.

    Zarrilli R , Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M, Villari P: Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 42, 946953 (2004)

    • Search Google Scholar
    • Export Citation
  • 3.

    Michele I , Laura V, Daniela F, Roberta B, Francesco I, Raoul JPB: et al.: Whole genome pyrosequencing of an epidemic multidrug – resistant A. baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother 25, 26162625 (2008)

    • Search Google Scholar
    • Export Citation
  • 4.

    Rosenthal S , Tager IB: Prevalence of gram negative rods in the normal pharyngeal flora. Ann Intern Med 83, 355357 (1975)

  • 5.

    Montefour K , Frieden J, Hurst S, Helmich C, Headley D, Martin M, Boyle DA: Acinetibacter baumannii. An emerging multidrug resistant pathogen in critical care. Critical Care Nurse 28, 1525 (2008)

    • Search Google Scholar
    • Export Citation
  • 6.

    Seifert H , Richter W, Pulverer G: Clinical and bacteriological features of relapsing shunt-associated meningitis due to Acinetibacter baumannii. Eur, J Clin Microbiol Infect Dis 14, 130134 (1995)

    • Search Google Scholar
    • Export Citation
  • 7.

    Peleg AY , Seifert H, Paterson DL: Acinetobacter baumannii: Emerging of a successful pathogen. Clin Microbiol Rev 21, 538582 (2008)

  • 8.

    Surasarang K , Narksawat K, Danchaivijitri, Siripanichgon K, Sujirarat G, Rongrungrueng Y, Kiratisin P.: Risk factors for multidrug resistant Acinetobacter baumannii nosocomial infection. J Med Assoc Thailand 90, 16331639 (2007)

    • Search Google Scholar
    • Export Citation
  • 9.

    Ling M L , Ang A, Wee M, Wang GC: A nosocomial outbreak of multiresistant Acinetobacter baumannii originating from an intensive care unit. Infect Control Hosp Epidemiol 22, 4849 (2001)

    • Search Google Scholar
    • Export Citation
  • 10.

    Clinical and Laboratory Standards Institute (2011): Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA

    • Search Google Scholar
    • Export Citation
  • 11.

    Olowe OA , Choudhary S, Schierack P, Wieler LH, Makanjuola OB, Olayemi AB, Anjum M: Pathotyping blaCTX-M Escherichia coli from Nigeria. Eur, J Microbiol Immunol 3(2), 120125 (2013)

    • Search Google Scholar
    • Export Citation
  • 12.

    Dijkshoorn L , Nemec A, Seifert H: An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5(12), 939951 (2007)

    • Search Google Scholar
    • Export Citation
  • 13.

    Siau H , Yuen KY, Wong SSY: The epidemiology of Acinetobacter infections in Hongkong, J Med Microbiol 44, 340347 (1996)

  • 14.

    Nabil K , Bjørg H, Kristin H, Gunnar SS, Arnfinn S, Ørjan S: Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother 10, 1093 (2001)

    • Search Google Scholar
    • Export Citation
  • 15.

    Namita J , Pushpa S, Lalit S: Acinetobacter baumannii isolates in a tertiary care hospital: antimicrobial resistance and clinical significance. J Clin Microbiol Infect 2(2), 5763 (2012)

    • Search Google Scholar
    • Export Citation
  • 16.

    Poutanen SM , Louie M, Simor AE: Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults. Eur, J Clin Microbiol Infect Dis 16(10), 737740 (1997)

    • Search Google Scholar
    • Export Citation
  • 17.

    Mera RM , Miller LA, Amrine-Madsen H, Sahm DF.: Acinetobacter baumannii 2002–2008: increase of carbapenem-associated multiclass resistance in the United States. Microb Drug Resist 16(3), 209215 (2010)

    • Search Google Scholar
    • Export Citation
  • 18.

    Prashanth K , Badrinath S: Nosocomial infections due to Acinetobacter species: clinical findings, risk and prognostic factors. Indian, J Med Microbiol 24, 3944 (2006)

    • Search Google Scholar
    • Export Citation
  • 19.

    Qin XP , Wang LY, Xu WJ: Acinetobacter baumannii infection in children and hospital infection control. Chin, J Nosocomiol 19, 13051307 (2009)

    • Search Google Scholar
    • Export Citation
  • 20.

    Dent LL , Marshall DR, Pratap S, Hulette RB: Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis 7, 196 (2010)

    • Search Google Scholar
    • Export Citation
  • 21.

    Baran G , Erbay A, Bodur H, Ongürü P, Akinci E, Balaban N, Cevik MA: Risk factors for nosocomial imipenem resistant Acinetobacter baumannii infections. Int, J Infect Dis 12, 1620 (2008)

    • Search Google Scholar
    • Export Citation
  • 22.

    Wang SH , Sheng WH, Chang YY, Wang LH, Lin HC, Chen ML, Pan HJ, Ko WJ, Chang SC, Lin FY: Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumanii in a surgical intensive care unit, J Hosp Infect 53, 97102 (2003)

    • Search Google Scholar
    • Export Citation
  • 23.

    Farahani KR , Moniri R, Shajari GH et al.: Antibiotic resistance patterns and the spread of antibiotic resistance genes in Acinetobacter species isolated from Kashan, Feyz, Kashan University of Medical Sci Health Serv 12(4), 6066 (2009)

    • Search Google Scholar
    • Export Citation
  • 24.

    Nseir S DI Pompeo C , Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A: Multiple-drug resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit Care Med 34, 29592966 (2006)

    • Search Google Scholar
    • Export Citation
  • 25.

    Gaur A , Garg A, Prakash P, Anupurba S, Mohapatra TM: Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India. J Health Popul Nutr 26, 183188 (2008)

    • Search Google Scholar
    • Export Citation
The author instruction is available in PDF.
Please, download the file from HERE.

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita

Editor(s)-in-Chief: Heimesaat, Markus M.

Vice Editor(s)-in-Chief: Fuchs, Anja

Editorial Board

Chair of the Editorial Board:
Jeffrey S. Buguliskis (Thomas Jefferson University, USA)

  • Jörn Albring (University of Münster, Germany)
  • Stefan Bereswill (Charité - University Medicine Berlin, Germany)
  • Dunja Bruder (University of Megdeburg, Germany)
  • Jan Buer (University of Duisburg, Germany)
  • Jeff Buguliskis (Thomas Jefferson University, USA)
  • Edit Buzas (Semmelweis University, Hungary)
  • Charles Collyer (University of Sydney, Australia)
  • Renato Damatta (UENF, Brazil)
  • Ivelina Damjanova (Semmelweis University, Hungary)
  • Maria Deli (Biological Research Center, HAS, Hungary)
  • Olgica Djurković-Djaković (University of Belgrade, Serbia)
  • Jean-Dennis Docquier (University of Siena, Italy)
  • Anna Erdei (Eötvös Loránd University, Hungary)
  • Zsuzsanna Fabry (University of Washington, USA)
  • Beniam Ghebremedhin (Witten/Herdecke University, Germany)
  • Nancy Guillen (Institute Pasteur, France)
  • Georgina L. Hold (University of Aberdeen, United Kingdom)
  • Ralf Ignatius (Charité - University Medicine Berlin, Germany)
  • Zsuzsanna Izsvak (MDC-Berlin, Germany)
  • Achim Kaasch (University of Cologne, Germany)
  • Tamás Laskay (University of Lübeck, Germany)
  • Oliver Liesenfeld (Roche, USA)
  • Shreemanta Parida (Vaccine Grand Challenge Program, India)
  • Matyas Sandor (University of Wisconsin, USA)
  • Ulrich Steinhoff (University of Marburg, Germany)
  • Michal Toborek (University of Miami, USA)
  • Mary Jo Wick (University of Gothenburg, Sweden)
  • Susanne A. Wolf (MDC-Berlin, Germany)


Dr. Dunay, Ildiko Rita
Magdeburg, Germany

Indexing and Abstracting Services:

  • PubMed Central
  • Scopus
  • ESCI
  • CABI


CrossRef Documents 23
WoS Cites 708
Wos H-index 27
Days from submission to acceptance 219
Days from acceptance to publication 176
Acceptance Rate 70%



European Journal of Microbiology and Immunology
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge 928 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

European Journal of Microbiology and Immunology
Language English
Size A4
Year of
2021 Volume 11
per Year
per Year
Founder Akadémiai Kiadó
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-509X (Print)
ISSN 2062-8633 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2021 0 7 3
Jul 2021 0 12 12
Aug 2021 0 7 9
Sep 2021 0 4 8
Oct 2021 0 7 6
Nov 2021 0 8 14
Dec 2021 0 0 0